SPC170
GLP-1 áhrifssamsetning (agonist composition) sem inniheldur að minnsta kosti eitt fjölpeptíð með GLP-1 virkni
Status:
AfskrifuðApplication date:
11.11.2016Application published:
15.12.2016
Medicine name:
Eperzan - albiglutideMedicine for children:
No
Timeline
Today
11.11.2016Application
15.12.2016Publication
Marketing license
IS authorization number:
EU/1/13/908/001-002Date:
9.4.2014
Foreign authorization number:
EU/1/13/908Date:
21.3.2014
Owner
Name:
GlaxoSmithKline LLCAddress:
Corporation Service Company 2711 Centerville Road Suite 400, Wilmington US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP1965823